Porcilis ColiClos

Authorised

This medicine is authorised for use in the European Union

vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Porcilis ColiClos : EPAR - Summary for the public

Product information

Porcilis ColiClos : EPAR - Product Information

Porcilis ColiClos : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Porcilis ColiClos
• Active substance:
  Clostridium perfringens type C / Escherichia coli F4ab / E. coli F4ac / E. coli F5 / E. coli F6 / E. coli LT
• International non-proprietary name (INN) or common name:
  vaccine to provide passive immunity to the progeny against Escherichia coli and Clostridium perfringens in pigs

Authorisation details

• EMA product number:
  EMEA/V/C/002011

Assessment history

Changes since initial authorisation of medicine

Porcilis ColiClos : EPAR - Procedural steps taken and scientific information after authorisation

CVMP post-authorisation summary of positive opinion for Porcilis ColiClos (VRA-0018-G)

Adopted Reference Number: EMA/CVMP/34688/2025

Initial marketing authorisation documents

Porcilis ColiClos : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Porcilis ColiClos

Adopted Reference Number: EMA/CVMP/135528/2012